Nor was it large enough to address the variant detection rates for the ovarian susceptibility genes RAD51C and RAD51D that have previously been excluded as breast cancer susceptibility genes [29,30], but which were more recently confirmed as breast cancer genes just reaching two-fold relative risk [16]. This evidence concerns the gene RAD51D and breast cancer.